ArticleJournal of neurology2025
Potential use of the SARS-CoV-2 monoclonal antibody sipavibart in people with multiple sclerosis: definition of different patient archetypes from an Italian expert group perspective.
Chiara Zanetta et al.PubMed ↗Publisher ↗
No numbers read from the abstract.